LETTER TO THE EDITOR

https://doi.org/10.5005/jp-journals-10071-24499
Indian Journal of Critical Care Medicine
Volume 27 | Issue 8 | Year 2023

COVID-19 Vaccine Associated with Cutaneous Involvement: Correspondence

Rujittika Mungmunpuntipantip1https://orcid.org/0000-0003-0078-7897, Viroj Wiwanitkit2https://orcid.org/0000-0003-1039-3728

1Private Academic Consultant, Bangkok, Thailand

2Department of Dental Sciences, Chandigarh University, Punjab, India

Corresponding Author: Rujittika Mungmunpuntipantip, Private Academic Consultant, Bangkok, Thailand, Phone: +66222566689, e-mail: rujittika@gmail.com

How to cite this article: Mungmunpuntipantip R, Wiwanitkit V. COVID-19 Vaccine Associated with Cutaneous Involvement: Correspondence. Indian J Crit Care Med 2023;27(8):599.

Source of support: Nil

Conflict of interest: None

Keywords: Adverse drug effects, COVID, Vaccine.

Dear Editor,

The authors hereby want to discuss and present ideas on the publication “COVID-19 Vaccine-associated Thrombosis (Disseminated Intravascular Thrombosis) with Rare Cutaneous Involvement”.1 Sinha and Tripathy reported a case and discussed on clinical interrelationships.1 All of us are concerned that the anti-SARS-CoV-2 immunization could bring medical problems despite its advantages. There is a challenge to identify the precise cause of the medical problem in the present case owing to limited data on the background health condition and immunological background of COVID-19 vaccine recipients before receiving anti-SARS-CoV-2 immunization. Ones might deny receiving vaccinations and have doubtfulness about the advantage if they receive conflicting data on immunization. A clinical problem occurring after immunization might be the reason for the mentioned issue.2,3 The prior COVID-19 is a big complicating factor. They can report talks about the effects of this component. Even though asymptomatic COVID-19 is not unusual, it cannot be completely ruled out without a full laboratory study.4

ORCID

Rujittika Mungmunpuntipantip https://orcid.org/0000-0003-0078-7897

Viroj Wiwanitkit https://orcid.org/0000-0003-1039-3728

REFERENCES

1. Sinha S, Tripathy S. COVID-19 vaccine-associated thrombosis (disseminated intravascular thrombosis) with rare cutaneous involvement. Indian J Crit Care Med 2022;26(8):963–965. DOI: 10.5005/jp-journals-10071-24282.

2. Kebayoon A, Wiwanitkit V. Dengue after COVID-19 vaccination: Possible and might be missed. Clin Appl Thromb Hemost 2021;27:10760296211047229. DOI: 10.1177/10760296211047229.

3. Sookaromdee P, Wiwanitkit V. Severe immune thrombocytopenia following COVID-19 vaccination. Am J Emerg Med 2022;58:337. DOI: 10.1016/j.ajem.2022.03.055.

4. Joob B, Wiwanitkit V. Letter to the editor: Coronavirus Disease 2019 (COVID-19), infectivity, and the incubation period. J Prev Med Public Health 2020;53(2):70. DOI: 10.3961/jpmph.20.065.

________________________
© The Author(s). 2023 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.